Effective gastric acid suppression after oral administration of enteric-coated omeprazole granules

被引:14
作者
Mohiuddin, MA [1 ]
Pursnani, KG [1 ]
Katzka, DA [1 ]
Gideon, RM [1 ]
Castell, JA [1 ]
Castell, DO [1 ]
机构
[1] GRAD HOSP PHILADELPHIA,DEPT MED,PHILADELPHIA,PA 19146
关键词
omeprazole; acid suppression; gastric secretion;
D O I
10.1023/A:1018839425118
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Omeprazole is inactivated by exposure to gastric acid and is formulated as a gelatin capsule containing enteric-coated granules that release the drug in alkaline medium. In clinical situations where patients are unable to take the capsule orally, the optimum means of administration is uncertain. Eleven normal volunteers were given omeprazole 20 mg every day for one week before breakfast in random order as either a 20-mg capsule with water or free enteric-coated granules with either 8 oz of orange juice, 8 oz of water with 2 Alka-Seltzer antacid tablets (aspirin free), or 1 teaspoon of apple sauce. On day 7 of each regimen, an 8-hr intragastric pH study was performed following omeprazole 20 mg and standard breakfast. The median percentage of time of gastric acid pH > 4 after an omeprazole capsule was 68.5 (25-100); after granules with orange juice 59 (43-100); after granules in Alka-Seltzer solution 63 (31-100), and after granules in apple sauce 65 (30-99), with no significant differences (ANOVA). The time for the gastric pH to reach <4' after having been above was also similar for all four regimens (ANOVA). Omeprazole granules administered orally in a variety of ways achieve gastric acid suppression as effectively as the intact capsule.
引用
收藏
页码:715 / 719
页数:5
相关论文
共 22 条
[1]  
ADAMS MH, 1988, CLIN PHARMACY, V7, P725
[2]   SLOW OMEPRAZOLE METABOLIZERS ARE ALSO POOR S-MEPHENYTOIN HYDROXYLATORS [J].
ANDERSSON, T ;
REGARDH, CG ;
DAHLPUUSTINEN, ML ;
BERTILSSON, L .
THERAPEUTIC DRUG MONITORING, 1990, 12 (04) :415-416
[3]  
BRACY N, 1995, GASTROENTEROLOGY, V108, pA62
[4]   OMEPRAZOLE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN PEPTIC-ULCER DISEASE AND ZOLLINGER-ELLISON SYNDROME [J].
CLISSOLD, SP ;
CAMPOLIRICHARDS, DM .
DRUGS, 1986, 32 (01) :15-47
[5]  
EARNEST DL, 1990, DICP ANN PHARMAC, V24, pS31
[6]   EFFECT OF SINGLE AND REPEATED DOSES OF ORAL OMEPRAZOLE ON GASTRIC-ACID AND PEPSIN-SECRETION AND FASTING SERUM GASTRIN AND SERUM PEPSINOGEN-I LEVELS [J].
FESTEN, HPM ;
TUYNMAN, HARE ;
DEFIZE, J ;
PALS, G ;
FRANTS, RR ;
STRAUB, JP ;
MEUWISSEN, SGM .
DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (06) :561-566
[7]   THE EFFECT OF OMEPRAZOLE ON GASTRIC-EMPTYING IN PATIENTS WITH DUODENAL-ULCER DISEASE [J].
HOROWITZ, M ;
HETZEL, DJ ;
BUCKLE, PJ ;
CHATTERTON, BE ;
SHEARMAN, DJC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (05) :791-794
[8]  
Kuo B, 1996, AM J GASTROENTEROL, V91, P1532
[9]   Bioavailability and efficacy of omeprazole given orally and by nasogastric tube [J].
Larson, C ;
Cavuto, NJ ;
Flockhart, DA ;
Weinberg, RB .
DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (03) :475-479
[10]   EFFECT OF OMEPRAZOLE - A GASTRIC PROTON PUMP INHIBITOR - ON PENTAGASTRIN STIMULATED ACID-SECRETION IN MAN [J].
LIND, T ;
CEDERBERG, C ;
EKENVED, G ;
HAGLUND, U ;
OLBE, L .
GUT, 1983, 24 (04) :270-276